Specifically, IDO1, a metabolic enzyme involved in tryptophan metabolism and an interferon-induced checkpoint molecule associated with immune suppression, has been linked to many types of cancer, such as acute myeloid leukaemia, ovarian cancer or colorectal cancer. This evidence concerns the gene IDO1 and acute myeloid leukemia.